Cite
HARVARD Citation
Postel-Vinay, S. et al. (2019). First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity. European journal of cancer. pp. 103-110. [Online].